Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 4,913 | 5,361 | 4,606 | 4,347 | 3,653 |
| Gross Profit | 4,913 | 5,361 | 4,606 | 4,347 | 3,653 |
| Operating Expenses | 18,387 | 19,212 | 17,575 | 19,224 | 12,953 |
| Operating Income | -13,474 | -13,851 | -12,969 | -14,877 | -9,300 |
| Interest Expense | 84 | 41 | 29 | 40 | 49 |
| Other Income | 129 | 269 | 526 | 767 | 1,019 |
| Pre-tax Income | -13,429 | -13,623 | -12,472 | -14,150 | -8,330 |
| Income Tax | N/A | N/A | N/A | N/A | -150 |
| Net Income Continuous | -13,429 | -13,623 | -12,472 | -14,150 | -8,180 |
| Net Income | $-13,429 | $-13,623 | $-12,472 | $-14,150 | $-8,180 |
| EPS Basic Total Ops | -0.59 | -0.60 | -0.55 | -0.64 | -0.36 |
| EPS Basic Continuous Ops | -0.59 | -0.60 | -0.55 | -0.63 | -0.36 |
| EPS Diluted Total Ops | -0.59 | -0.60 | -0.55 | -0.64 | -0.36 |
| EPS Diluted Continuous Ops | -0.59 | -0.60 | -0.55 | -0.63 | -0.36 |
| EBITDA(a) | $-12,913 | $-13,332 | $-12,464 | $-14,420 | $-8,917 |